We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MBRF3:BMFBOVESPAMBRF Global Foods Company S.A. Analysis

Data as of 2026-03-15 - not real-time

R$16.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MBRF3 is trading at R$16.90, well below its DCF‑derived fair value of R$33.31, implying an upside of roughly 46 %.
The stock sits under its 20‑day (R$18.81), 50‑day (R$19.08) and 200‑day (R$20.85) simple moving averages, confirming a bearish technical backdrop. Momentum indicators are also weak, with the RSI at 33 (near oversold) and a bearish MACD histogram of –0.32. Price is hovering just above the identified support of R$16.16 and well below the resistance level of R$21.17, suggesting limited near‑term upside unless a bounce occurs. The company offers an eye‑catching dividend yield of 33.4 %, but the payout ratio exceeds 340 % of earnings, raising serious sustainability concerns. Fundamentals show a low trailing PE of 10.2 and a price‑to‑book of 1.99, yet margins are thin (gross 12.5 %, operating 3.8 %) and debt‑to‑equity is extremely high at 468, flagging balance‑sheet risk. Cash generation remains solid, with operating cash flow of R$19.2 bn and free cash flow of R$5.2 bn, providing some cushion for debt servicing. Volatility is elevated at 37.5 % over the past 30 days, while beta is modest (0.21), indicating price swings are driven more by company‑specific factors than market moves. The sector—Consumer Defensive—typically offers resilience, but MBRF’s heavy exposure to Brazil and its food‑processing operations adds medium geographic and regulatory risk. Analyst consensus (15 analysts) leans Buy with a median target of R$25.3, well above current levels. Given the valuation gap, strong cash flow, and the potential for debt reduction, the stock appears undervalued from a value‑oriented perspective. However, the unsustainable dividend and high leverage suggest caution, making a balanced, medium‑term buying stance prudent.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support level
  • oversold RSI suggests potential bounce
  • high dividend unsustainability raises caution

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • valuation gap to DCF fair value
  • strong operating cash flow supports debt reduction
  • analyst consensus and target price upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • persistent cash generation
  • potential improvement in leverage
  • stable consumer defensive demand

Key Metrics & Analysis

Financial Health

Revenue Growth6.70%
Profit Margin1.76%
P/E Ratio10.2
ROE11.40%
ROA2.56%
Debt/Equity468.29
P/B Ratio2.0
Op. Cash FlowR$19.2B
Free Cash FlowR$5.2B

Technical Analysis

TrendBearish
RSI33.2
SupportR$16.16
ResistanceR$21.17
MA 20R$18.81
MA 50R$19.08
MA 200R$20.85
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair ValueR$33.31
Target PriceR$24.81
Upside/Downside46.79%
GradeUndervalued
TypeValue
Dividend Yield33.40%

Risk Assessment

Beta0.21
Volatility37.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.